Upsher-Smith Labs on Wednesday announced that it has agreed to acquire Proximagen Group, a European biotechnology company focused on the development and commercialization of novel therapeutics for diseases of the central nervous system and inflammation.
A worldwide provider of managed videoconferencing, telepresence and visual collaboration services has partnered with Telemed Ventures to deliver a managed visual collaboration solution to Walmart's retail medical clinics.
In the spirit of the London 2012 Olympic Games, Procter & Gamble’s Always feminine care brand has partnered with track and field athlete Veronica Campbell-Brown to start running the Always “Baton Connection” Facebook program.
Red Carpet Manicure, an at-home LED gel manicure and pedicure system, has announced that it is expanding to Canada with plans to launch the system at London Drug, Rexall and The Shopping Channel in June.
Procter & Gamble’s CoverGirl brand has signed U.S. Olympic hopefuls Jennifer Kessy (women’s beach volleyball) and Marlen Esparza (women’s boxing) to represent the beauty brand. In addition, LashBlast Volume and Outlast All-Day Lipcolor will be available in special, limited-edition packaging to honor both women as they compete in the London 2012 Olympic Games.
A decade ago, Unilever’s Axe revolutionized the American grooming industry with its launch and has since become a leading men’s grooming brand. Now the brand is aiming to make history again with its first-ever fragrance for her. Enter Anarchy.
Procter & Gamble’s Pantene hair care brand will support 11 female athletes as its newest beauty ambassadors. The group will be featured in Pantene’s first global marketing campaign to support the Olympic Games.
Procter & Gamble Beauty has partnered with Alicia Sacramone, Beijing 2008 Olympic Games silver medalist, who will serve as an ambassador for P&G beauty brands, including CoverGirl, Olay, Pantene and Secret.
Patent expirations of key blockbuster drugs and efforts by payers to contain costs are likely to bring strong growth to the global generic drug market in the next few years as market-earned revenues grow by more than $100 billion, according to an analysis by research firm Frost & Sullivan.